Drug Type Small molecule drug |
Synonyms Clopidogrel/levamlodipine, Levamlodipine/clopidogrel, S-amlodipine besylate/clopidogrel bisulphate tablet |
Target |
Action modulators |
Mechanism P2Y12 receptor modulators(Purinergic receptor P2Y12 modulators), VDCCs modulators(Voltage-gated calcium channel modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H31ClN2O8S |
InChIKeyZPBWCRDSRKPIDG-LMOVPXPDSA-N |
CAS Registry150566-71-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Phase 3 | - | - | |
Thrombosis | Phase 3 | - | - |